Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (NBIX) — Form 144: Proposed sale of shares
About this filing
Neurocrine Biosciences, Inc. (NBIX) filed Form 144 (proposed sale of shares) with the SEC on Oct 30, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.
Key facts
- Seller
- GEORGE MORROW
- Relationship
- Director
- Shares to sell
- 300
- Market value
- $43,914.00
- Approximate sale date
- Oct 30, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Oct 30, 2026 · Exercise of Stock Options
Rule 10b5-1 plan · adopted May 26, 2026
More NBIX filings
- SC 13G
Filed Oct 30, 2026
- SC 13G/A
Filed Oct 15, 2026
- 3
Filed Oct 7, 2026
- 8-K
Filed Sep 28, 2026
- 4
Filed Sep 15, 2026
- 4
Filed Sep 15, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.